Skip to main content

Scientists discover way to eliminate chemotherapy side effects in mice

chemotherapy side effects eliminated 123rf
Image used with permission by copyright holder
Anyone who has been through cancer, or had a loved one battle it, will be grateful that we live in a world in which chemotherapy exists. One thing they probably won’t be so grateful for are the terrible side effects that accompany chemo — which can include muscle weakness, nausea, dizziness, and more.

Which is why it’s exciting to hear that scientists have published a paper describing how these side effect might be nullified.

“Chemotherapeutic drugs are an effective anti-cancer strategy but come with a number of side effects due to the lack of specificity against cancer cells,” Dr. Marco Demaria, a co-author in the study from the Netherlands’ University of Groningen, told Digital Trends. “During this study, we have shown that a number of these drugs can promote cellular aging, also known as cellular senescence, in many tissues independently of tumors. Eliminating senescent cells from the body using a transgenic mouse model was sufficient to reduce several toxicities associated to the treatment, and improve animals’ healthspan. Moreover, cancer relapse was delayed.”

In other words, in animal tests with mice suffering from cancer, the symptoms of four common chemotherapy drugs (doxorubicin, cisplatin, paclitaxel and temozolomide) could be gotten rid of by giving them drugs to kill the senescent cells.

As to the billion dollar question of whether similar findings can be extrapolated to humans, there is reason to be optimistic. The researchers discovered that a higher number of senescent cells pre-chemotherapy correlated with increased fatigue after treatment in breast cancer human patients: a similar finding to the way that mice behaved.

“We are now planning different studies to expand the correlation between cellular senescence and chemotherapy,” Demaria continued. “Our goal is to develop compounds that could interfere with senescent cells to generate combinatorial treatments with low toxicities and high efficacy. However, we need to keep in consideration that senescent cells cover a number of beneficial functions for the organism, and currently we are not able to discriminate and target only the deleterious senescence. Deep characterizations of the different types of senescent cells are needed to design drugs for human treatment.”

To put it another way, don’t expect overnight results, but the prognosis is looking positive!

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
This AI cloned my voice using just three minutes of audio
acapela group voice cloning ad

There's a scene in Mission Impossible 3 that you might recall. In it, our hero Ethan Hunt (Tom Cruise) tackles the movie's villain, holds him at gunpoint, and forces him to read a bizarre series of sentences aloud.

"The pleasure of Busby's company is what I most enjoy," he reluctantly reads. "He put a tack on Miss Yancy's chair, and she called him a horrible boy. At the end of the month, he was flinging two kittens across the width of the room ..."

Read more
Digital Trends’ Top Tech of CES 2023 Awards
Best of CES 2023 Awards Our Top Tech from the Show Feature

Let there be no doubt: CES isn’t just alive in 2023; it’s thriving. Take one glance at the taxi gridlock outside the Las Vegas Convention Center and it’s evident that two quiet COVID years didn’t kill the world’s desire for an overcrowded in-person tech extravaganza -- they just built up a ravenous demand.

From VR to AI, eVTOLs and QD-OLED, the acronyms were flying and fresh technologies populated every corner of the show floor, and even the parking lot. So naturally, we poked, prodded, and tried on everything we could. They weren’t all revolutionary. But they didn’t have to be. We’ve watched enough waves of “game-changing” technologies that never quite arrive to know that sometimes it’s the little tweaks that really count.

Read more
Digital Trends’ Tech For Change CES 2023 Awards
Digital Trends CES 2023 Tech For Change Award Winners Feature

CES is more than just a neon-drenched show-and-tell session for the world’s biggest tech manufacturers. More and more, it’s also a place where companies showcase innovations that could truly make the world a better place — and at CES 2023, this type of tech was on full display. We saw everything from accessibility-minded PS5 controllers to pedal-powered smart desks. But of all the amazing innovations on display this year, these three impressed us the most:

Samsung's Relumino Mode
Across the globe, roughly 300 million people suffer from moderate to severe vision loss, and generally speaking, most TVs don’t take that into account. So in an effort to make television more accessible and enjoyable for those millions of people suffering from impaired vision, Samsung is adding a new picture mode to many of its new TVs.
[CES 2023] Relumino Mode: Innovation for every need | Samsung
Relumino Mode, as it’s called, works by adding a bunch of different visual filters to the picture simultaneously. Outlines of people and objects on screen are highlighted, the contrast and brightness of the overall picture are cranked up, and extra sharpness is applied to everything. The resulting video would likely look strange to people with normal vision, but for folks with low vision, it should look clearer and closer to "normal" than it otherwise would.
Excitingly, since Relumino Mode is ultimately just a clever software trick, this technology could theoretically be pushed out via a software update and installed on millions of existing Samsung TVs -- not just new and recently purchased ones.

Read more